RecallDepth
Class II Terminated

Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated, CA, NDC 51407-322-30

Company
Golden State Medical Supply Inc.
Recall Initiated
October 6, 2022
Posted
October 26, 2022
Recall Number
D-0012-2023
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Camarillo, CA, United States

Reason for Recall

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

Distribution

USA nationwide

Lot / Code Info

Lot #: GS036715, GS037569, GS038132, GS038665, GS038750, GS039565, GS039997, GS040673, Exp 10/31/2022; GS040674, GS041237, GS041652, GS042152, GS043365, Exp 3/31/2023; GS045441, GS045677, GS046111, Exp 2/29/2024.

More recalls by Golden State Medical Supply Inc.

View all recalls by this company →

Other recent Class II Drug recalls